相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Interruption of antiretroviral therapy initiated during primary HIV-1 infection:: Impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 randomized study
Cecile Goujard et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes
Philipp Kaiser et al.
JOURNAL OF VIROLOGY (2007)
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: Implications for secondary transmission
Davey M. Smith et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions
Beda Joos et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
GARD: a genetic algorithm for recombination detection
Sergei L. Kosakovsky Pond et al.
BIOINFORMATICS (2006)
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection
Hendrik Streeck et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection
Frederick M. Hecht et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells
Kara G. Lassen et al.
PLOS PATHOGENS (2006)
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions
B Joos et al.
JOURNAL OF VIROLOGY (2005)
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1
MC Strain et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA
M Sharkey et al.
JOURNAL OF VIROLOGY (2005)
Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?
DE Smith et al.
AIDS (2004)
Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities
N Frahm et al.
JOURNAL OF VIROLOGY (2004)
Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy
M Fischer et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The causes and consequences of HIV evolution
A Rambaut et al.
NATURE REVIEWS GENETICS (2004)
Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef
M Fischer et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Limited durability of viral control following treated acute HIV infection
DE Kaufmann et al.
PLOS MEDICINE (2004)
DnaSP, DNA polymorphism analyses by the coalescent and other methods
J Rozas et al.
BIOINFORMATICS (2003)
Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences
MA Jensen et al.
JOURNAL OF VIROLOGY (2003)
Emergence of minor populations of human immunodeficiency virus type 1 carrying the M184V and L90M mutations in subjects undergoing structured treatment interruptions
KJ Metzner et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years
DV Havlir et al.
JOURNAL OF VIROLOGY (2003)
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection
C Fagard et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy
LM Frenkel et al.
JOURNAL OF VIROLOGY (2003)
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV:: Intrinsic stability predicts lifelong persistence
MC Strain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection
A Brussel et al.
AIDS (2003)
A new perspective on V3 phenotype prediction
S Pillai et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
HIV RNA in plasma rebounds within days during structured treatment interruptions
M Fischer et al.
AIDS (2003)
Human immunodeficiency virus type 1 fitness is a determining factor in viral rebound and set point in chronic infection
A Trkola et al.
JOURNAL OF VIROLOGY (2003)
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals
J Martinez-Picado et al.
JOURNAL OF VIROLOGY (2002)
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection
A Oxenius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
G Greub et al.
AIDS (2002)
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
S Walmsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication
TC Pierson et al.
JOURNAL OF VIROLOGY (2002)
Prevalence and predictive value of intermittent viremia with combination HIV therapy
DV Havlir et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Residual HIV-1 infection during antiretroviral therapy: the challenge of viral persistence
RJ Pomerantz
AIDS (2001)
HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection
L Ruiz et al.
AIDS (2001)
Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years
HF Günthard et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy
H Imamichi et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy
LQ Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
TW Chun et al.
NATURE MEDICINE (2000)
分享论文
